DCOY insider filings

Decoy Therapeutics Inc. — 10 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen DCOY transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 10 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Burleson Tess — Director1——1
Gauthier Patricia G. — Director1——1
HANISH ARNOLD C — Director1——1
Hibner Barbara Louise — Chief Scientific Officer1——1
Lammers Paul — Director1——1
Lieber Jonathan I — Director1——1
Marschel Peter Klaus — Chief Business Officer1——1
McVicar William K. — Director1——1
PIERCE FREDERICK II — Chief Executive Officer1——1
Rosenblum Mark J — Chief Financial Officer1——1

Recent insider filings — Decoy Therapeutics Inc.

FiledFormInsiderReported transactionsSource
2026-09-024Lieber Jonathan I — DirectorGrant/award (A): 2,000 @ $0EDGAR
2026-09-024Hibner Barbara Louise — Chief Scientific OfficerGrant/award (A): 4,216 @ $0EDGAR
2026-09-024Rosenblum Mark J — Chief Financial OfficerGrant/award (A): 9,682 @ $0EDGAR
2026-09-024Marschel Peter Klaus — Chief Business OfficerGrant/award (A): 3,900 @ $0EDGAR
2026-09-024PIERCE FREDERICK II — Chief Executive OfficerGrant/award (A): 33,455 @ $0EDGAR
2026-09-024Lammers Paul — DirectorGrant/award (A): 2,000 @ $0EDGAR
2026-09-024HANISH ARNOLD C — DirectorGrant/award (A): 3,000 @ $0EDGAR
2026-09-024Gauthier Patricia G. — DirectorGrant/award (A): 2,000 @ $0EDGAR
2026-09-024McVicar William K. — DirectorGrant/award (A): 3,000 @ $0EDGAR
2026-09-024Burleson Tess — DirectorGrant/award (A): 2,000 @ $0EDGAR

Recent 8-K events — Decoy Therapeutics Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-09-238-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-07-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-298-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-198-K?
8.01 — Other Events
EDGAR
2026-04-028-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-058-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-01-088-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR

Registration filings — Decoy Therapeutics Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DCOY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs